Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
ABT-751 With Chemotherapy for Relapsed Pediatric ALL
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
- Status
- COMPLETED
- Phase
- NA
Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder
- Status
- WITHDRAWN
- Phase
- PHASE3
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
05-001: Treatment of Acute Lymphoblastic Leukemia in Children
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.
- Status
- COMPLETED
- Phase
- PHASE2
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3